Careers Company News
He is one of the more recognisable names and faces in the pharmaceutical industry, and sales maestro Scott Graves isn’t […]
Jun 17th, 2022
Jun 17th, 2022
Is plastic bioprocess containment the right pill for the pharmaceutical industry? When it comes to secondary packaging, you face a choice between plastic and steel.
Which way to go? Back in 1999’s The Matrix, Neo faced a similar choice when Morpheus offered the chosen ‘One’ a choice between popping the blue or the red pill.
“You take the blue pill – the story ends,” says Morpheus. “You take the red pill – you stay in Wonderland and I show you how deep the rabbit hole goes.”
Plastic bioprocess containers are akin to the red pill for the pharmaceutical industry. For those who are yet to move to plastic containment, the dream of plastic remains just that: a dream.
But for those who already embrace plastic containment, the dream world is now the real world, a place where cost-savings and supply chain rationalisation have become the norm.
Those who take the red pill enjoy:
Fabricating in plastic means ALLpaQ bioprocess containers can be easily collapsed and stacked, allowing pharmaceutical companies to maximise warehouse floor space. This also presents space and cost benefits when in shipment.
ALLpaq bioprocess containers can be used time and time again and, unlike stainless steel containers, in the event of damage individual panels can be removed and replaced. This in turn adds to the lifespan of your fleet, enhancing sustainability and your profit margins.
Plastic is easier to clean than steel and can be quickly jet washed. If needed, individual panels can also be removed for cleaning.